 Home > Biochemical Engineering > Polypeptide > Eptifibatide for Sale > Eptifibatide Peptide API

Eptifibatide Peptide API buy - large image1

Eptifibatide Peptide API

Name: Eptifibatide Peptide API
Brand: Thinheal Pharma
SKU: pr2605191659
Price: 30 USD
Availability: InStock

COA 2 Inquiries

Unit Price: Get Latest Price 

CAS No.:

188627-80-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Hangzhou

Brand:

Thinheal Pharma

Packaging:

50g/bottle 100g/bottle

Price valid (until):

2026-06-19

Contact Supplier

 Chat Now

Hangzhou Thinheal Pharma

Company Type:

Manufactory

Location:

China

Qualification:

Main Products:

Semaglutide,Retatrutide,Tirzepatide,Linaclotide

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Description

Eptifibatide is a synthetic cyclic heptapeptide derived from the venom of the southeastern pygmy rattlesnake (Sistrurus miliarus barbourin). It acts as a selective and reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, which is the final common pathway for platelet aggregation.

By binding to the GP IIb/IIIa receptor, eptifibatide prevents the binding of fibrinogen, von Willebrand factor, and other adhesive ligands to platelets, thereby inhibiting platelet aggregation in a dose- and concentration-dependent manner. The drug has a rapid onset of action and a short plasma half-life of approximately 2.5 hours, allowing for quick recovery of platelet function after discontinuation.

Eptifibatide is indicated for the treatment of patients with acute coronary syndrome (unstable angina/non-ST-segment elevation myocardial infarction), including those receiving medical treatment or undergoing percutaneous coronary intervention (PCI). It is also indicated for patients undergoing PCI, including those receiving intracoronary stent placement, to reduce the risk of death, new myocardial infarction, or the need for urgent intervention.

Key Features:

Selective GP IIb/IIIa receptor antagonist
Reversible and short-acting (half-life ~2.5 hours)
Rapid onset of action
Indicated for ACS and PCI patients
FDA-approved therapy
Manufactured under cGMP standards

Clinical Use:

Administered as an intravenous bolus followed by continuous infusion
Used in combination with aspirin and heparin
Reduces ischemic complications in ACS and PCI patients

Specifications:

Parameter	Specification
Purity	≥98% (≥99% available)
CAS No.	148031-34-9
Molecular Formula	C₃₅H₄₉N₁₁O₉S₂
Molecular Weight	~832.0 g/mol
Peptide Sequence	Mpa-Har-Gly-Asp-Trp-Pro-Cys-NH₂ (cyclic disulfide bridge)
Storage	2-8°C, dry, protected from light
Shelf Life	24 months

Applications:

Acute coronary syndrome (ACS) research
Percutaneous coronary intervention (PCI) studies
Platelet aggregation inhibition research
Cardiovascular pharmacology
Antithrombotic drug development

Why Choose Us:

cGMP certified manufacturing
≥98-99% purity by HPLC
Comprehensive documentation (COA, stability data, DMF)
24-month shelf life
Reliable global supply with temperature-controlled shipping

Documentation Available:

Certificate of Analysis (COA)
Stability study data (24 months)
GMP statement
DMF (available upon request)

Contact Us

For pricing, DMF status, or sample requests, please contact our sales team.

Certificates

Basic Info

Product Name:

Eptifibatide

Other Name:

MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2

CAS No.:

188627-80-7

Molecular Formula:

C35H49N11O9S2

InChIKeys:

CZKPOZZJODAYPZ-UHFFFAOYSA-N

Molecular Weight:

831.96

Exact Mass:

831.315613

EC Number:

1312995-182-4

DSSTox ID:

DTXSID7046673

Categories:

Polypeptide

Characteristics

PSA:

377 Å²

XLogP3:

log Kow = -4.33 (est)

Density:

1.6±0.1 g/cm3

Refractive Index:

1.735

Water Solubility:

In water, 1108 mg/L at 25 °C (est)

Storage Conditions:

Eptifibatide should be refrigerated at between 2-8 °C and protected from light until administration.|Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature -20 °C. Store with desiccant. /Eptifibatide acetate/

Vapor Pressure:

1.78X10-40 mm Hg at 25 °C (est)

Henrys Law Constant:

Henry's Law constant = 9.88X10-34 atm-cu m/mol at 25 °C (est)

Experimental Properties:

Hydroxyl radical reaction rate constant = 6.79X10-10 cu cm/molec-sec at 25 °C (est)

See More Eptifibatide Properties 

Hazard Identification

Classification of the substance or mixture

Specific target organ toxicity â single exposure, Category 1

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Danger
Hazard statement(s)	H370 Causes damage to organs
Prevention	P260 Do not breathe dust/fume/gas/mist/vapours/spray. P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response	P308+P316 IF exposed or concerned: Get emergency medical help immediately. P321 Specific treatment (see ... on this label).
Storage	P405 Store locked up.
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More Eptifibatide Safety Data Sheet 

Seller Information

Business Type:
Manufactory

Main Products:
Semaglutide,Retatrutide,Tirzepatide,Linaclotide

Location:
8th Floor, Building 2, Phase 5, Xiasha Heda Pharmaceutical Valley, Qiantang District, Hangzhou, Zhejiang Province

Payment Terms:
TT against copy of documents

Average lead Time:
7

Total Annual Revenue:
$25 million-$50 million

Total Employees:
301-500

Year of Establishment:
2019

Certifications:
WC,GMP

杭州信海医药科技有限公司成立于2019年，是一家专注于多肽产品的研发、生产、销售与定制、研发生产相结合的生物医药企业。核心管理团
队由具有深厚医药专业背景的专业人士组成。信海医药建有一个研发中心和两个生产基地，目前化学合成多肽总产能已达数吨级规模。

公司具备完整高效的多肽研发、生产及销售体系，提供全方位的多肽产业化服务，包括原料药研发和生产业务、制剂研发业务、多肽定制研发生产（CDMO）业务、以及美容肽研发生产业务。现阶段产品主要包括司美格鲁肽、替尔泊肽、利那洛肽、瑞塔鲁肽等数十个品种，其中司美格鲁肽、替尔泊肽、利那洛肽等多个品种已完成美国FDA DMF备案。
公司以固、液相结合的化学合成工艺手段为驱动，建有复杂多肽及类肽化学合成及修饰平台、多肽片段设计与合成技术平台、多分离手段纯化平台等完善研发体系，拥有一支130人以上研发队伍，博士、硕士学历人员占比近20%，核心研发团队拥有超过20年的多肽药物开发经验，具备深厚的专业背景和丰富的实践经验.

Inquiry History

2 Inquiries

Country	Product	Purchase Quantity	Date Posted
Uzbekistan	Eptifibatide	60 G	Dec 10, 2023
India	Eptifibatide	10 G	May 13, 2026

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Supplier Name	Details
Eptifibatide, CAS No.: 188627-80-7	Pharmaceutical Grade/98.0	DALIAN HANDOM CHEMICALS CO.,LTD.	Inquiry
Eptifibatide cas188627-80-7 treat acute coronary syndrome high purity 99%	Pharmaceutical Grade/99		Inquiry
Eptifibatide	/99.00	HANGZHOU LEAP CHEM CO., LTD.	Inquiry
delivery to USA Eptifibatide Acetate 99% white powder kanbei	Pharmaceutical Grade/99	Henan Lihao Chem Plant Limited	Inquiry
Eptifibatide-	Pharmaceutical Grade/99	chemtour	Inquiry